The Pattern of Guillain-Barré Syndrome
Guillain-Barré syndrome follows a characteristic triphasic pattern: acute progressive ascending weakness reaching maximum disability within 2 weeks, followed by a plateau phase, then gradual recovery over months to years. 1, 2
Classic Clinical Pattern
Temporal Course
- Progression phase: Weakness develops acutely or subacutely, with most patients reaching maximum disability within 2 weeks of symptom onset 1, 2
- Plateau phase: Stabilization occurs, typically after progression stops within 4 weeks (if progression continues beyond 4 weeks, consider alternative diagnoses like A-CIDP) 3, 4
- Recovery phase: Improvement begins and can continue for more than 3 years after onset, with 60-80% of patients able to walk independently by 6 months 1, 2
- The disease course is monophasic in the vast majority of cases, though treatment-related fluctuations and relapses occur in 2-5% of patients 3, 2
Neurological Pattern
- Bilateral ascending weakness is the hallmark, typically starting in the legs and progressing proximally to involve arms and cranial muscles 1, 2
- Areflexia or hyporeflexia develops early, beginning in the lower limbs and eventually affecting most patients at nadir 1, 5
- Distal paresthesias or sensory loss often precede or accompany the motor weakness 1, 2
- Weakness is symmetrical and bilateral, though it can occasionally be asymmetrical or have atypical distribution patterns 3
Associated Features
- Preceding infection: Approximately two-thirds of patients report infectious symptoms within the 6 weeks before GBS onset, most commonly Campylobacter jejuni, cytomegalovirus, hepatitis E virus, Mycoplasma pneumoniae, Epstein-Barr virus, or Zika virus 3, 2
- Pain: Muscular, radicular, or neuropathic pain affects approximately two-thirds of patients and is often an early symptom 1, 2
- Cranial nerve involvement: Bilateral facial palsy is common, and other cranial nerves may be affected 3, 1
- Dysautonomia: Blood pressure/heart rate instability, pupillary dysfunction, and bowel/bladder dysfunction occur frequently 1, 2
- Respiratory failure: Develops in approximately 20% of patients, requiring mechanical ventilation 2, 6
Clinical Variants
While the classic sensorimotor pattern represents 70% of cases in Europe and the Americas, several distinct variants exist 1:
Major Variants
- Pure motor variant (5-70% of cases): Motor weakness without sensory signs; may show normal or exaggerated reflexes in AMAN subtype 3, 1, 7
- Miller Fisher syndrome (5-25% of cases): Ophthalmoplegia, ataxia, and areflexia with minimal limb weakness 3, 1, 7
- Pharyngeal-cervical-brachial weakness: Weakness limited to upper limbs and bulbar muscles 3
- Paraparetic variant: Weakness restricted to lower limbs 3
- Bilateral facial palsy with paresthesias: Cranial nerve-limited presentation 3
Atypical Presentations
- Weakness can start in the arms, legs, or simultaneously in all limbs rather than following strict ascending pattern 3
- Severe diffuse pain or isolated cranial nerve dysfunction may precede weakness 3
- Young children (<6 years) may present with poorly localized pain, refusal to bear weight, irritability, meningism, or unsteady gait 3
Diagnostic Pattern Recognition
CSF Pattern
- Albuminocytologic dissociation (elevated protein with normal cell count) typically appears at the end of the first week and may persist until the third week 1, 7
- Critical caveat: Normal CSF protein in the first week does not exclude GBS 1
- Marked CSF pleocytosis should prompt reconsideration of the diagnosis 1
Electrophysiological Patterns
- AIDP (most common in Europe/North America): Demyelinating features including reduced conduction velocities, temporal dispersion, and conduction blocks 7, 4, 8
- AMAN/AMSAN (more common in Asia): Axonal degeneration pattern with reduced amplitudes but preserved conduction velocities 7, 8
- "Sural sparing pattern": Normal sural sensory nerve action potential with abnormal median/ulnar responses is typical 1
Prognostic Pattern
- Mortality: 3-10% even with optimal medical care 2
- Full recovery: Expected in approximately 90% of cases, though recovery may take up to 2 years 1
- Severe disability: Approximately 20% of patients remain severely disabled 8
- Recurrence: Rare, occurring in only 2-5% of cases 1, 2